Discover how quantitative analysis can illuminate hedge fund performance, offering insights into risk metrics and benchmarks ...

Moderna & Merck announce 5-year data for intismeran autogene in combo with Keytruda demonstrated sustained improvement in primary endpoint of recurrence-free survival in patients with high-risk stage ...